Friday, July 29, 2022

Gene therapy induces sustained and normalised levels of factor IX in haemophilia B

Gene therapy use in a phase 2 trial for patients with haemophilia B induced sustained increases in factor IX levels in virtually all patients.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...